Studies have found that cordycepin combined with doxorubicin may have activity against glioblastoma through proteoglycans in cancer, the TNF signaling pathway, microRNA in cancer, pathways in cancer, and other pathways. The gene discussed is TNF; the disease is glioblastoma.